uploads/2018/11/Chart-04-3-1.jpg

iAnthus Capital Holdings’ Valuation as of November 30

By

Updated

iAnthus’s valuation

iAnthus Capital Holdings (ITHUF) is a leading company in the cannabis industry (SEED). This article compares iAnthus Capital’s valuation to those of its peers, including MPX Bioceutical (MPXEF), MariCann (MRRCF), and MedMen (MMNFF).

The chart above compares the valuation multiples of iAnthus Capital Holdings to those of its peers.

Article continues below advertisement

Forward PE

iAnthus Capital Holdings was trading at a forward PE multiple of ~35.5x on November 30 compared to the industry average of ~41.5x. Peers MPX Bioceutical (MPXEF) and MedMen were trading at forward PE multiples of 34.7x and 103.7x, respectively.

Forward EV-to-EBITDA

On a capital-structure-neutral basis, iAnthus Capital Holdings was trading at a forward EV-to-EBITDA (enterprise value-to-EBITDA) multiple of ~7.1x, marginally higher than the industry average of ~54.3x, on November 30. Peers MPX Bioceutical (MPXEF), MariCann, and MedMen were trading at forward EV-to-EBITDA multiples of 10.2x, 19.9x, and 161.9x, respectively.

Forward EV-to-revenue

iAnthus Capital Holdings was trading at a forward EV-to-revenue multiple of ~1.4x, lower than the industry average of ~3.2x, on November 30. Peers MPX Bioceutical, MariCann, and MedMen were trading at forward EV-to-revenue multiples of 2.5x, 2.3x, and 4.1x, respectively, compared to MedMen.

Advertisement

More From Market Realist